Laparoscopic ileocolic resection versus infliximab treatment of recurrent distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).

Trial Profile

Laparoscopic ileocolic resection versus infliximab treatment of recurrent distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2015

At a glance

  • Drugs Infliximab (Primary) ; Prednisolone
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Acronyms LIRIC
  • Most Recent Events

    • 25 Aug 2013 Status changed from completed to recruiting as reported by Netherlands Trial Register record.
    • 30 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top